What in the World Happened to XenoPort?

Talk about a reversal of fortune. XenoPort (XNPT) was soaring in pre-market action, jumping as much as 16% after it released positive top line preliminary results from a mid-stage study testing its experimental psoriasis medication XP23829. The company plans to initiate late-stage trials in 2016. But now the stock has reversed course, plunged almost 12.8% to a […]